The Role of Daratumumab in Complications Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Prospective Study on PRCA and AIHA

Scientists conducted a prospective monocentric investigation assessing the use of daratumumab in complications following allo-HSC transplantation. All treated patients, except one, reached transfusion independence with erythropoietin suspension.